Table 2 Characteristics of the included studies
PROM | Reference | Sample Size | Age, y | Female, % | Clinical Details | Setting | Country | Language | Response Rate |
|---|---|---|---|---|---|---|---|---|---|
SF-36 | Burney 1996 | 59 | Mean 59.9 (range 30–86) | 77% | PHPT | Outpatient | USA | English | Baseline: NR 2 months: 67.8% 6 months: 39.0% |
|  | Burney 1998 | 140 | Mean 58 (range 21–85) | 74% | PHPT | Outpatient | USA | English | Baseline: NR 2 months: 78.6% 6 months: 48.5% |
| Â | Burney 1999 | 155 | Low calcium group: mean 57 High calcium group: mean 59 | Low calcium group: 71% High calcium group: 74% | PHPT; considered two groups above (high calcium) and below (low calcium) 10.9Â mg/dL | Outpatient | USA | English | Baseline: NR 2 months: NR 6 months: 67.1% |
PAS | Pasieka 1998 | 63 | Mean 54 (range 13–80) | 75% | PHPT vs. thyroid disease (n = 54) | Outpatient | Canada | English | Baseline: NR 1 week: NR 3 months: NR 12 months: NR |
|  | Pasieka 2002 | 203 (Australia: 27, USA: 54, Canada: 122) | Australia: mean 52 (range 15–76) USA: mean 52 (range 25–77) Canada: mean 55 (range 13–81) | Australia: 100% USA: 65% Canada: 73% | PHPT vs. thyroid disease (n = 58 from Canada) | Outpatient | Australia, USA, Canada | English | Australia Baseline: 100% 1 week: 100% 3 months: 100% 12 months: 0% USA Baseline: 100% 1 week: 100% 3 months: 100% 12 months: 100% Canada Baseline: NR 1 week: NR 3 months: NR 12 months: NR |
|  | Mihai and Sadler 2008 | 101 | Mean 61 (SD 17; range 18–89 years) | 70.3% | PHPT | Outpatient | UK | English | Baseline: 100% 3 months: 73.3% 6 months: 48.5% 12 months: 67.3% |
| Â | Tzikos 2022 | 50 | Mean 64 (SD 12.7) | NR | PHPT | Outpatient | Greece | Greek | Baseline: 100% 1 month: 100% |
PHPQoL | Webb 2013 | 67 | Mean 59.2 (SD 13.4) | 69.7% | PHPT | Outpatient | Spain | Spanish | 80.9% |
| Â | Webb 2016 | 182 | Mean 61.4 (SD 12.1) | 79.7% | PHPT | Outpatient | Spain | Spanish | NR |